Peripheral nerve injury reduces the ability of macrophages to clear dead or dying cells – a process known as efferocytosis – leading to chronic pain Restoring efferocytosis ability reduced neuropathic ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process could help improve recovery ...

Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...

Newron Pharmaceuticals expands IP portfolio for evenamide with new European Union composition of matter patent: Milan, Italy Thursday, January 8, 2026, 14:00 Hrs [IST] Newron Phar ...

Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...

Ad hoc announcement pursuant to Art. 53 LR EP4615820 "Crystalline Forms of Evenamide" is expected to extend asset exclusivity in EU into 2044 Evenamide is currently being investigated in Newron's ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...